Loyens & Loeff advised Coloplast on acquisition of Atos Medical
Loyens & Loeff has advised Coloplast A/S, a multinational company listed on Nasdaq Copenhagen.
Coloplast A/S develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care, on its acquisition of the Atos Medical group, the global market leader in laryngectomy, for EUR 2.155 billion (around DKK 16 billion) from PAI Partners, a global private equity firm headquartered in Paris. Closing of the transaction is subject to customary regulatory approvals and anticipated to occur in Q2 2021/22.
Dries Fransen van de PutteSenior Associate Attorney at law
Dries Fransen van de Putte, attorney at law, is a member of the Corporate practice group of our firm. He is also a member of the life sciences team and the healthcare team of Loyens & Loeff.T: +31 20 578 56 34 M: +31 6 22 10 94 21 E: [email protected]
Jet de Mol van OtterlooAssociate Attorney at law
Jet de Mol van Otterloo, associate, is a member of the Competition & Regulatory practice group in our Amsterdam office. She focuses on corporate law (mergers & acquisitions) in the healthcare sector.T: +31 20 578 5833 M: +31 6 52 00 59 69 E: [email protected]
Céline van WaesbergeSenior Associate Attorney at law
Céline van Waesberge, attorney at law, works for the Competition & Regulatory practice group and is member of the Life Sciences Team and Data Protection & Privacy Team of Loyens & Loeff.T: +31 20 578 52 25 M: +31 6 11 44 26 95 E: [email protected]